APA (7th ed.) Citation

Tsakalozou, E., Alam, K., Babiskin, A., & Zhao, L. (2022). Physiologically-Based Pharmacokinetic Modeling to Support Determination of Bioequivalence for Dermatological Drug Products: Scientific and Regulatory Considerations. Clinical pharmacology and therapeutics, 111(5), 1036. https://doi.org/10.1002/cpt.2356

Chicago Style (17th ed.) Citation

Tsakalozou, Eleftheria, Khondoker Alam, Andrew Babiskin, and Liang Zhao. "Physiologically-Based Pharmacokinetic Modeling to Support Determination of Bioequivalence for Dermatological Drug Products: Scientific and Regulatory Considerations." Clinical Pharmacology and Therapeutics 111, no. 5 (2022): 1036. https://doi.org/10.1002/cpt.2356.

MLA (9th ed.) Citation

Tsakalozou, Eleftheria, et al. "Physiologically-Based Pharmacokinetic Modeling to Support Determination of Bioequivalence for Dermatological Drug Products: Scientific and Regulatory Considerations." Clinical Pharmacology and Therapeutics, vol. 111, no. 5, 2022, p. 1036, https://doi.org/10.1002/cpt.2356.